Core Viewpoint - The company, Sino Medical (688108.SH), has successfully received approval from Brazil's National Health Surveillance Agency (ANVISA) for its SC HONKYTONK TM coronary balloon dilation catheter, which is designed to improve myocardial perfusion by dilating narrowed segments of coronary arteries or bypass grafts [1] Group 1 - The company submitted the registration application for the SC HONKYTONK TM coronary balloon dilation catheter to ANVISA in November 2024 [1] - The approval from ANVISA indicates a significant milestone for the company in expanding its product offerings in the Brazilian market [1] - The SC HONKYTONK TM product is specifically aimed at treating coronary artery stenosis, which is a critical area in cardiovascular health [1]
赛诺医疗:冠脉球囊产品在海外获注册证